Skip to content
HowShorted

Paratek Pharmaceuticals, Inc. short interest in 2021

In 2021, Paratek Pharmaceuticals, Inc.'s disclosed short interest ran from 8.92% of shares outstanding on 15 Jan 2021 to 7.49% on 31 Dec 2021, a change of -1.43 percentage points. The year's high was 9.80% on 26 Feb 2021 and its low 6.56% on 15 Dec 2021, averaging 8.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.56 days on 14 May 2021. Full history: Paratek Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Paratek Pharmaceuticals, Inc. in 2021

2021 in figures

Start of year
8.92% (15 Jan 2021)
End of year
7.49% (31 Dec 2021)
Change
-1.43 pp
High
9.80% (26 Feb 2021)
Low
6.56% (15 Dec 2021)
Average
8.64%
Highest days to cover
18.56 (14 May 2021)
SEC filings marked
4

Every report in 2021

Paratek Pharmaceuticals, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20218.92%12.63
29 Jan 20218.82%13.50
12 Feb 20219.64%7.44
26 Feb 20219.80%10.50
15 Mar 20219.75%11.76
31 Mar 20219.33%16.1510-K filed
15 Apr 20219.00%4.97
30 Apr 20219.35%16.22
14 May 20219.08%18.56
28 May 20219.01%15.6510-Q filed
15 Jun 20219.36%5.06
30 Jun 20218.81%3.85
15 Jul 20218.72%9.05
30 Jul 20218.98%13.22
13 Aug 20219.07%7.9510-Q filed
31 Aug 20219.45%8.39
15 Sep 20219.22%13.38
30 Sep 20218.26%9.28
15 Oct 20217.64%15.88
29 Oct 20217.14%12.78
15 Nov 20217.13%12.9410-Q filed
30 Nov 20216.84%12.05
15 Dec 20216.56%12.87
31 Dec 20217.49%11.69

See also: Paratek Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.